The anti-obesity potential of sigmoidin A

References

• Abubakari AR, Bhopal RS. (2008). Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity in Ghanaians and Nigerians. Public Health, 122, 173–182.
   PubMed Web of Science ®Google Scholar
• Ballinger A, Peikin SR. (2002). Orlistat: Its current status as an anti-obesity drug. Eur J Pharmacol, 440, 109–117.
   PubMed Web of Science ®Google Scholar
• CDC (Centres for disease control and prevention). (2012). U.S. Obesity Trends. http://www.cdc.gov/obesity/data/trends.HTML. Accessed on 6 April 2012.
   Google Scholar
• Chen Y-H, Chang F-R, Lin Y-J, Hsieh P-W, Wu M-J, Wu Y-C. (2008). Identification of antioxidants from rhizome of Davallia solida. Food Chem 107, 684–691.
   Google Scholar
• Cui L, Ndinteh DT, Na M, Thuong PT, Silike-Muruumu J, Njamen D, Mbafor JT, Fomum ZT, Ahn JS, Oh WK. (2007). Isoprenylated flavonoids from the stem bark of Erythrina abyssinica. J Nat Prod, 70, 1039–1042.
   PubMed Web of Science ®Google Scholar
• Diabetes UK (2012). Diabetes and obesity. Available at: http://www.diabetes.co.uk/diabetes-and-obesity.html. Accessed on 6 April 2012.
   Google Scholar
• Fomum ZT, Ayafor JF, Mbafor JT. (1983). Erythrina studies: Part 1. Novel antibacterial flavanones from Erythina sigmoidea. Tet Lett, 24, 4127–4130.
   Google Scholar
• Galati G, Sabzevari O, Wilson JX, O’Brien PJ. (2002). Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 177, 91–104.
   PubMed Web of Science ®Google Scholar
• Golay A, Ybarra J. (2005). Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab, 19, 649–663.
   PubMed Web of Science ®Google Scholar
• Habtemariam S. (2011). A-glucosidase inhibitory activity of kaempferol-3-O-rutinoside. Nat Prod Commun, 6, 201–203.
   PubMed Web of Science ®Google Scholar
• Habtemariam S, Dagne E. (2010). Comparative antioxidant, prooxidant and cytotoxic activity of sigmoidin A and eriodictyol. Planta Med, 76, 589–594.
   PubMedGoogle Scholar
• Haslam D. (2010). Obesity and diabetes: The links and common approaches. Prim Care Diabetes, 4, 105–112.
   PubMed Web of Science ®Google Scholar
• Ichimaru M, Moriyasu M, Nishiyama Y, Kato A. (1996). Structural elucidation of new flavanones isolated from Erythrina abyssinica. J Nat Prod, 59, 111–116.
   Google Scholar
• Lee ER, Kim JH, Choi HY, Jeon K, Cho SG. (2011). Cytoprotective effect of eriodictyol in UV-irradiated keratinocytes via phosphatase-dependent modulation of both the p38 MAPK and Akt signaling pathways. Cell Physiol Biochem, 27, 513–524.
   PubMedGoogle Scholar
• Lee JK. (2011). Anti-inflammatory effects of eriodictyol in lipopolysaccharide-stimulated raw 264.7 murine macrophages. Arch Pharm Res, 34, 671–679.
   PubMed Web of Science ®Google Scholar
• Njamen D, Mbafor JT, Fomum ZT, Kamanyi A, Mbanya JC, Recio MC, Giner RM, Máñez S, Ríos JL. (2004). Anti-inflammatory activities of two flavanones, sigmoidin A and sigmoidin B, from Erythrina sigmoidea. Planta Med, 70, 104–107.
   PubMed Web of Science ®Google Scholar
• Narváez-Mastache JM, Novillo F, Delgado G. (2008). Antioxidant aryl-prenylcoumarin, flavan-3-ols and flavonoids from Eysenhardtia subcoriacea. Phytochemistry, 69, 451–456.
   PubMedGoogle Scholar
• Ogata S, Miyake Y, Yamamoto K, Okumura K, Taguchi H. (2000). Apoptosis induced by the flavonoid from lemon fruit (Citrus limon BURM. f.) and its metabolites in HL-60 cells. Biosci Biotechnol Biochem, 64, 1075–1078.
   PubMed Web of Science ®Google Scholar
• Padwal RS, Majumdar SR. (2007). Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. Lancet, 369, 71–77.
   PubMed Web of Science ®Google Scholar
• PHAC (Public Health Agency of Canada) (2012). Obesity in Canada. Available at: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/index-eng.php. Accessed on 6 April 2012.
   Google Scholar
• Polednak AP. (2003). Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect Prev, 27, 415–421.
   PubMedGoogle Scholar
• Rossato MF, Trevisan G, Walker CI, Klafke JZ, de Oliveira AP, Villarinho JG, Zanon RB, Royes LF, Athayde ML, Gomez MV, Ferreira J. (2011). Eriodictyol: A flavonoid antagonist of the TRPV1 receptor with antioxidant activity. Biochem Pharmacol, 81, 544–551.
   PubMedGoogle Scholar
• Roselli M, Lentini G, Habtemariam S. (2011). Phytochemical, antioxidant and anti-α-glucosidase activity evaluations of Bergenia cordifolia. Phytother Res. DOI: 10.1002/ptr.3655.
   Google Scholar
• Schoeller DA. (2008). Insights into energy balance from doubly labeled water. Int J Obes (Lond), 32 Suppl 7, S72–S75.
   Google Scholar
• Tsimogiannis DI, Oreopoulou V. (2004). Free radical scavenging and antioxidant activity of 5,7,3′,4′-hydroxy-substituted flavonoids. Innov Food Sci Emerg Technol 5, 523–528.
   Google Scholar
• Tsimogiannis DI, Oreopoulou V. (2006). The contribution of flavonoid C-ring on the DPPH free radical scavenging efficiency. A kinetic approach for the 3′,4′-hydroxy substituted members. Innov Food Sci Emerg Technol 7, 140–146.
   Web of Science ®Google Scholar
• Visscher TL, Seidell JC. (2001). The public health impact of obesity. Annu Rev Public Health, 22, 355–375.
   PubMed Web of Science ®Google Scholar
• WHO (2012). Obesity: Facts and figures. Available at: http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/obesity/facts-and-figures. Accessed on 6 April 2012.
   Google Scholar
• Yenesew A, Induli M, Derese S, Midiwo JO, Heydenreich M, Peter MG, Akala H, Wangui J, Liyala P, Waters NC. (2004). Anti-plasmodial flavonoids from the stem bark of Erythrina abyssinica. Phytochemistry, 65, 3029–3032.
   PubMed Web of Science ®Google Scholar
• Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. (2006). Epidemic obesity and type 2 diabetes in Asia. Lancet, 368, 1681–1688.
   PubMed Web of Science ®Google Scholar
• You Q, Chen F, Wang X, Jiang Y, Lin S. (2012). Anti-diabetic activities of phenolic compounds in muscadine against alpha-glucosidase and pancreatic lipase. LWT - Food Sci Technol, 46, 164–168.
   Web of Science ®Google Scholar
• Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. (2011). Impact of obesity on cardiovascular disease. Med Clin North Am, 95, 919–937.
   PubMedGoogle Scholar
• Zhang L, Li J, Hogan S, Chung H, Welbaum GE, Zhou K. (2010).Inhibitory effect of raspberries on starch digestive enzyme and their antioxidant properties and phenolic composition. Food Chem, 119, 592–599.
   Web of Science ®Google Scholar